These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22744437)

  • 21. Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma.
    Onal C; Topuk S; Yapar AF; Yavuz M; Topkan E; Yavuz A
    Onkologie; 2013; 36(9):484-90. PubMed ID: 24051924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
    Lake ES; Wadhwani S; Subar D; Kauser A; Harris C; Chang D; Lapsia S
    Ann R Coll Surg Engl; 2014 Apr; 96(3):211-5. PubMed ID: 24780786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
    Kajitani C; Asakawa I; Uto F; Katayama E; Inoue K; Tamamoto T; Shirone N; Okamoto H; Kirita T; Hasegawa M
    J Radiat Res; 2013 Jul; 54(4):671-8. PubMed ID: 23287772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
    Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
    Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET-CT fusion in radiation management of patients with anorectal tumors.
    Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
    Krengli M; Milia ME; Turri L; Mones E; Bassi MC; Cannillo B; Deantonio L; Sacchetti G; Brambilla M; Inglese E
    Radiat Oncol; 2010 Feb; 5():10. PubMed ID: 20137093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
    Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
    Mao W; Zhou J; Qiu L; Yin H; Tan H; Shi H
    Abdom Radiol (NY); 2020 Apr; 45(4):1075-1081. PubMed ID: 31927618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
    Katoh N; Yasuda K; Shiga T; Hasegawa M; Onimaru R; Shimizu S; Bengua G; Ishikawa M; Tamaki N; Shirato H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e671-6. PubMed ID: 22245187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
    Soydal C; Kucuk ON; Gecim EI; Bilgic S; Elhan AH
    Nucl Med Commun; 2013 May; 34(5):501-6. PubMed ID: 23478586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
    Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
    J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
    Annunziata S; Treglia G; Caldarella C; Galiandro F
    ScientificWorldJournal; 2014; 2014():879469. PubMed ID: 24672385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.